We Provide PCR Innovation and Solutions

HealthTrackRx is the nation’s leading PCR-based infectious disease laboratory, advancing healthcare through decentralized patient-directed testing, large-scale surveillance pathogen testing, antimicrobial stewardship, and value-based care programs. In a global environment threatened by growing antimicrobial resistance, rapid diagnoses matter. HealthTrackRx sets the pace for industry-leading laboratory operations through unparalleled turnaround time, yielding insights that mobilize accurate clinical decisions. With over 20 years in the clinical laboratory industry, HealthTrackRx provides services to over 10,000 clinicians nationwide.

We set the pace for industry-leading

Laboratory Operations With Unparalleled:

HealthTrackRx Turn Around Time

Turnaround time

We provide exceptional results delivery time, returning results within 24 hours of sample receipt

HealthTrackRx Accuracy

Accuracy 

Our best-in-class PCR tests deliver ~99% accuracy in both sensitivity and specificity for samples

HealthTrackRx Service

Service

Our technology easily integrates with EMR systems and we deliver results via our Client Web Portal

HealthTrackRx Identification

Identification

We combat antibiotic resistance effectively, identifying pathogens that are difficult to culture

HealthTrackRx Collection

Collection

We offer SimpliSWAB™, a universal tube containing a proprietary collection medium for ALL sample types

Why

We Exist

HealthTrackRx has assumed an active leadership role in our industry by educating the healthcare community about Antimicrobial Resistance (AMR), which is recognized by the CDC and WHO as one of the greatest threats to public health worldwide1. AMR occurs when bacteria mutate over time and no longer respond to antibiotics, making infections challenging to treat and increasing the risk of disease spread, severe illness and death.2

HealthTrackRx provides proprietary solutions to AMR, promoting appropriate use of antibiotics to Antimicrobial Stewardship Programs (ASPs) in healthcare settings. Research shows that rapid PCR diagnostics combined with Antimicrobial Stewardship initiatives produces the most rapid organism identification and antimicrobial de-escalation.3

We assist providers in increasing Antimicrobial Stewardship via our Personalized Antibiogram available on every sample results report, which removes guesswork by detecting antibiotic resistance genes, and helps patients receive an antibiotic that works – the first time. Our partnership with you produces increasingly positive patient outcomes while mitigating rising healthcare costs.

We are placing focus on the evolution of clinical diagnostic testing in the delivery of healthcare and directing continued trends within the laboratory industry towards decentralized, patient-directed testing, large-scale surveillance pathogen testing, antimicrobial stewardship, and value-based care programs.

Martin Price

Executive Chairman and Chairman of the Board

Our Technology

HealthTrackRx’s pathogen assay incorporates the latest in RT-PCR technology to rapidly and reliably analyze your patient’s sample. We utilize both Siemens Healthineers and Thermo Fisher technology, providing results with the highest specificity and sensitivity in the market. Our assay accurately detects and differentiates ~99%4 of the most relevant viral, bacterial and fungal pathogens.

Clinical Studies

Click The Links Below To Read Clinical Studies Published By The HealthTrackRx Department of Molecular Diagnostics

Meet

Our Leadership

Executive Chairman & CEO

Martin
Price

Chief Financial Officer

Steve
Armond

Chief Commercial Officer

John
Moore

Chief Operating Officer

Guhan
Raghu

Chief Growth & Strategy Officer

Michael
Bennett

General Counsel

Kendra
Green Dias

Senior Vice President of
Laboratory & Clinical Strategy

Jay
Reddy, PHD

Meet

Our Advisory Board

Our advisors are extraordinary healthcare leaders representing public health policy, research, and clinical thought leadership. Their collective skills and industry expertise help to guide our executive team in their efforts to fuel ongoing growth and development.

Barbara Alexander, M.D., FIDSA
President, Infectious Disease Society of America 2020-2021

Leah Binder
President and CEO of Leapfrog Group

Elizabeth Canis
Former VP for Emerging Business and Partnerships at Anthem

Barry Eisenstein, M.D
Chief Medical Officer and former Chair of the Scientific and Business Advisory Board of CARB-X

Eric D. Hargan
Former Acting Secretary, US Dept of Health and Human Services

Get In Touch With Our Team

Contact Us